A Florida family is sharing their story in hopes that their tragedy can bring awareness to others to know the risk of warm waters after their son died due to a brain-eating amoeba.Tanner Wall loved the water, but his parents believe it's what was in the water at a Florida lake that took his life…
The Florida Department of Health confirmed a case of what is commonly referred to as a brain-eating amoeba in the Tampa area. According to the department, one person in Hillsborough County contracted Naegleria fowleri, which is a single-cell amoeba that attacks brain tissue and is usually fatal. Since 1962, there have been only 37 cases…
Skip to content pic.twitter.com/icT66tqlkU— DOH - Hillsborough (@DOHHillsborough) July 3, 2020 Health officials did not disclose the person's identity or the body of water where the person might have been infected, The Tampa Bay Times reported. A person can be infected through contaminated water entering their nose. The amoeba is more prevalent during the summer months…
A person in Florida has been infected with a rare and usually deadly brain-eating amoeba, according to health officials.The Florida Department of Health announced Friday that one patient in Hillsborough County has been infected with Naegleria fowleri, a water-borne,microscopic single-celled amoeba that attacks the brain."Infections can happen when contaminated water enters the body through the…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment